GENERATE - Næste GENERATION af gynækologisk kirurgi - Robotassisteret kirurgi i gynækologiske indikationer (GENERATE)
GENERETER - Næste GENERATION af gynækologisk kirurgi - Robotassisteret kirurgi i gynækologiske indikationer - En prospektiv, ikke-interventionel, multicenter, postmarkedsklinisk undersøgelse
GENERATE - Next GENERATion of GynEcological Surgery - Robotic Assisted Surgery in Gynecological Indications
Generate real-world evidence in the use of the da Vinci Surgical Systems for gynecological indications within the German health care system.
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Detaljeret beskrivelse
A prospective, non-interventional, multi-center, post market clinical study.
Undersøgelsestype
Undersøgelsestype
Tilmelding (Anslået)
Tilmelding
Kontakter og lokationer
Studiekontakt
Studiekontakt
- Navn: Petra Kremer
- Telefonnummer: +49 151 62679136
- E-mail: petra.kremer@intusurg.com
Undersøgelse Kontakt Backup
- Navn: Peter Appenrodt
- Telefonnummer: +49 173 2043740
- E-mail: peter.appenrodt@intusurg.com
Studiesteder
-
-
-
Berlin, Tyskland, 13353
- Aktiv, ikke rekrutterende
- Charité - Universitätsmedizin Berlin - Klinik für Gynäkologie
-
Bochum, Tyskland, 44791
- Aktiv, ikke rekrutterende
- Augusta-Kranken-Anstalt Bochum
-
Coburg, Tyskland, 96450
- Aktiv, ikke rekrutterende
- Sana Kliniken Coburg
-
Cologne, Tyskland, 50935
- Afsluttet
- St. Elisabeth-Krankenhaus Köln-Hohenlind
-
Essen, Tyskland, 45147
- Aktiv, ikke rekrutterende
- Universitätsklinikum Essen
-
Frankfurt am Main, Tyskland, 60431
- Aktiv, ikke rekrutterende
- Agaplesion Markus Krankenhaus Frankfurt am Main
-
Freiburg im Breisgau, Tyskland, 79106
- Rekruttering
- Universitätsklinikum Freiburg - Klinik für Frauenheilkunde
-
Kontakt:
- Markus Hübner, Prof. Dr.
-
Greifswald, Tyskland, 17475
- Rekruttering
- Universitätsmedizin Greifswald
-
Kontakt:
- Zaher Alwafai, Dr.
- Telefonnummer: +49 3834 86 6500
- E-mail: zaher.alwafai@med.uni-greifswald.de
-
Höxter, Tyskland, 37671
- Aktiv, ikke rekrutterende
- St. Ansgar Krankenhaus Höxter
-
Kiel, Tyskland, 24105
- Aktiv, ikke rekrutterende
- Universitätsklinikum Kiel
-
Nuremberg, Tyskland, 90419
- Aktiv, ikke rekrutterende
- Klinikum Nürnberg Nord / Klinik für Frauenheilkunde
-
Schwerin, Tyskland, 19055
- Aktiv, ikke rekrutterende
- Helios Kliniken Schwerin
-
Tübingen, Tyskland, 72076
- Aktiv, ikke rekrutterende
- Universitätsklinikum Tübingen - Frauenklinik
-
-
Free and Hanseatic City of Hamburg
-
Hamburg, Free and Hanseatic City of Hamburg, Tyskland, 22457
- Aktiv, ikke rekrutterende
- Albertinen Krankenhaus Hamburg
-
-
Hesse
-
Wiesbaden, Hesse, Tyskland, 65189
- Aktiv, ikke rekrutterende
- St. Josefs-Hospital Wiesbaden
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Patients with gynecological disease that may be treated by surgical intervention.
Beskrivelse
Key Inclusion Criteria:
- Woman with 18 years of age or older
- Patient is willing to participate and to comply with the study procedures as demonstrated by signing the informed consent
- Patient is a candidate for a gynecological procedure to be performed with the Intuitive Surgical System
Key Exclusion Criteria:
- Life expectancy of less than 1 year
- Pregnancy, or positive pregnancy test for women prior to menopause or breastfeeding women
- Current participation in a clinical study, if not pre-approved by Intuitive
- Individuals who are unable to fully understand all aspects of the study that are relevant to the decision to participate (mentally or verbally), or who could be manipulated or unduly influenced as a result of a compromised position, expectation of benefits or fear of retaliation
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Observationsmodeller: COHORT
- Tidsperspektiver: PROSPECTIVE
Antal grupper/kohorter
Kohorter og interventioner
Gruppe / kohorteGruppe / kohorte |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
da Vinci Patients
Consecutive enrollment of patients with indications of interest and having a da Vinci robotic-assisted surgery |
Robotic-assisted surgery (da Vinci) |
|
Epidemiological Data Audit
Extended data collection on patients with indications of interest, eligible for a robotic-assisted surgery, but treatment choice was not a da Vinci surgery |
Non-da Vinci Surgery |
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Number of complications related to the surgery up to 30 days
Tidsramme: 30 days
|
Describe the number of complications related to the surgery up to 30 days; adverse events as documented during the first 30 days will be classified as four different levels of causality to the surgery (not related, possible, probable and causal relationship). Descriptive analysis will be performed. |
30 days
|
|
Describe the number of patient-reported outcomes up to 12 months
Tidsramme: 12 months
|
Describe the patient-reported outcomes up to 12 months; descriptive analysis will be performed on the data directly reported via the patients (patient questionnaires); information included are number of complications, re-hospitalizations, re-operations, disease recurrence, disease remission, new disease diagnosis and pain status including pain medication |
12 months
|
|
Characterize the treatment decision as reported by the treating physician
Tidsramme: 30 days
|
Characterize the treatment decision per data provided by the treating physician (within the study database) including the rationale given for the treatment decision (e.g., age of the patient or co-morbidity); number of treatment decisions, e.g., for surgical therapy (open surgery or minimal-invasive therapy), watchful waiting, or treatment with medication will be described; descriptive analysis will be performed |
30 days
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Investigate the impact of patient characteristics on surgery
Tidsramme: 30 days
|
Descriptive analysis of patient characteristics such as age on surgery (e.g., duration of surgery, instrument usage) |
30 days
|
|
Investigate the impact of patient characteristics on clinical outcome
Tidsramme: 30 days
|
Descriptive analysis of patient characteristics such as age on clinical outcome (e.g., re-operation) |
30 days
|
|
Investigate the impact of patient characteristics on complications
Tidsramme: 30 days
|
Descriptive analysis of patient characteristics such as age on complication (number of complications reported during and after the surgery) |
30 days
|
|
Describe the impact from surgery to the patient's quality of life and function
Tidsramme: 12 months
|
Describe the impact from surgery to the patient's quality of life and function by comparing the baseline quality of life and functional status with the post-operative status (post-operative day 1-3, 30 days, 90 days, 6 months and 12 months) |
12 months
|
|
Describe the number of Intuitive instruments used per procedure and patient characteristics
Tidsramme: 30 days
|
Describe the number of Intuitive instruments used per procedure and patient characteristics; descriptive analysis will be performed on the number of instruments used per specific procedure and patient |
30 days
|
|
Describe the number of disease recurrence and re-operation at final patient follow-up
Tidsramme: 12 months
|
Describe the number disease recurrence and re-operation at final patient follow-up; descriptive analysis will be performed |
12 months
|
|
Describe the number of conversion per procedure and patient characteristics
Tidsramme: 30 days
|
Describe the number conversion per procedure and patient characteristics; descriptive analysis will be performed |
30 days
|
|
Describe the impact of surgeon experience on surgical times (duration of surgery per treating surgeon)
Tidsramme: 30 days
|
Describe the impact of surgeon experience on surgical times, descriptive analysis will be performed on the surgical times (duration of surgery) per treating surgeon |
30 days
|
|
Describe the impact of surgeon experience on clinical outcome (number of clinical outcomes per treating surgeon)
Tidsramme: 30 days
|
Describe the impact of surgeon experience on clinical outcome; descriptive analysis will be performed, e.g., on number of re-operation or re-hospitalization per treating surgeon |
30 days
|
|
Describe the impact of surgeon experience on complications (number of events per surgeon)
Tidsramme: 30 days
|
Describe the impact of surgeon experience on complications; descriptive analysis will be performed on number of adverse events per treating surgeon |
30 days
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Efterforskere
Efterforskere
- Ledende efterforsker: Ingolf Juhasz-Böss, Prof. Dr., University Hospital Freiburg
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Studiestart
Primær færdiggørelse (Anslået)
Primær færdiggørelse
Studieafslutning (Anslået)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Urogenitale sygdomme
- Genitale sygdomme
- Urogenitale sygdomme hos kvinder
- Kvinders urogenitale sygdomme og graviditetskomplikationer
- Kønssygdomme, kvindelige
- Kirurgiske procedurer, operative
- Teknologi, industri og landbrug
- Automatisering
- Teknologi
- Kirurgi, computerassisteret
- Robotik
- Robotkirurgiske procedurer
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- 114363C
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
produkt fremstillet i og eksporteret fra U.S.A.
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .